Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit
Rani Therapeutics, a Nasdaq-listed clinical-stage biotherapeutics company (RANI), has announced its participation in the 2024 Maxim Healthcare Virtual Summit. The company, which focuses on oral delivery of biologics and drugs, will be represented by CEO Talat Imran and CFO Svai Sanford in a fireside chat.
The event is scheduled for Thursday, October 17, 2024, from 11:30 am to 12:00 pm E.T. in Track 2. Interested parties can access the live webcast of the conference through a provided registration link. This participation highlights Rani Therapeutics' engagement with the investment community and its commitment to sharing insights about its innovative approach to drug delivery.
Rani Therapeutics, un'azienda biotecnologica in fase clinica quotata al Nasdaq (RANI), ha annunciato la sua partecipazione al 2024 Maxim Healthcare Virtual Summit. L'azienda, che si concentra sulla somministrazione orale di biologici e farmaci, sarà rappresentata dal CEO Talat Imran e dal CFO Svai Sanford in una chiacchierata informale.
L'evento è programmato per giovedì 17 ottobre 2024, dalle 11:30 alle 12:00 E.T. nel Traccia 2. Le parti interessate possono accedere alla trasmissione in diretta della conferenza tramite un link di registrazione fornito. Questa partecipazione evidenzia l'impegno di Rani Therapeutics con la comunità degli investitori e il suo impegno a condividere le intuizioni sul suo approccio innovativo alla somministrazione dei farmaci.
Rani Therapeutics, una empresa biotecnológica en fase clínica cotizada en Nasdaq (RANI), ha anunciado su participación en el 2024 Maxim Healthcare Virtual Summit. La empresa, que se centra en la administración oral de biológicos y medicamentos, será representada por el CEO Talat Imran y el CFO Svai Sanford en una charla informal.
El evento está programado para el jueves 17 de octubre de 2024, de 11:30 a.m. a 12:00 p.m. E.T. en la Pista 2. Las partes interesadas pueden acceder a la transmisión en vivo de la conferencia a través de un enlace de registro proporcionado. Esta participación destaca el compromiso de Rani Therapeutics con la comunidad inversora y su dedicación a compartir conocimientos sobre su enfoque innovador en la administración de medicamentos.
Rani Therapeutics는 나스닥에 상장된 임상 단계의 생물의약품 회사(RANI)로서 2024 Maxim Healthcare Virtual Summit에 참여한다고 발표했습니다. 생물학적 제제 및 약물의 경구 전달에 중점을 둔 이 회사는 CEO Talat Imran과 CFO Svai Sanford가 대화식 세션에서 발표할 예정입니다.
이 행사는 2024년 10월 17일 목요일 오전 11시 30분부터 낮 12시까지 E.T. Track 2에서 진행됩니다. 관심 있는 분들은 제공된 등록 링크를 통해 회의의 실시간 웹 방송에 접근할 수 있습니다. 이번 참여는 Rani Therapeutics가 투자자 커뮤니티와의 관계를 강화하고 혁신적인 약물 전달 방안에 대한 통찰력을 공유하겠다는 의지를 나타냅니다.
Rani Therapeutics, une entreprise de biothérapeutiques en phase clinique cotée au Nasdaq (RANI), a annoncé sa participation au 2024 Maxim Healthcare Virtual Summit. L'entreprise, qui se concentre sur l'administration orale de biologiques et de médicaments, sera représentée par le PDG Talat Imran et le CFO Svai Sanford lors d'une discussion informelle.
L'événement est prévu pour le jeudi 17 octobre 2024, de 11h30 à 12h00 E.T. dans la Piste 2. Les parties intéressées peuvent accéder à la diffusion en direct de la conférence via un lien d'inscription fourni. Cette participation met en lumière l'engagement de Rani Therapeutics envers la communauté d'investissement et son engagement à partager des idées sur son approche innovante de l'administration de médicaments.
Rani Therapeutics, ein an der Nasdaq gelistetes biopharmazeutisches Unternehmen in der klinischen Phase (RANI), hat seine Teilnahme am 2024 Maxim Healthcare Virtual Summit angekündigt. Das Unternehmen, das sich auf die orale Verabreichung von Biologika und Arzneimitteln spezialisiert hat, wird von CEO Talat Imran und CFO Svai Sanford in einem Gespräch vertreten.
Die Veranstaltung ist für Donnerstag, den 17. Oktober 2024, von 11:30 bis 12:00 Uhr E.T. in Track 2 geplant. Interessierte können über einen bereitgestellten Registrierungslink auf die Live-Übertragung der Konferenz zugreifen. Diese Teilnahme unterstreicht das Engagement von Rani Therapeutics für die Investoren-Community und das Bestreben, Einblicke in ihren innovativen Ansatz zur Arzneimittelverabreichung zu teilen.
- None.
- None.
SAN JOSE, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the company’s Chief Executive Officer, Talat Imran, and Chief Financial Officer, Svai Sanford, will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit on Thursday, October 17, 2024 from 11:30 am – 12:00 pm E.T. in Track 2.
Interested parties can register and access the live webcast for the conference here.
About Rani Therapeutics
Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill® capsule, which is a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill® capsule technology. For more information, visit ranitherapeutics.com.
Investor Contact:
investors@ranitherapeutics.com
Media Contact:
FAQ
When is Rani Therapeutics (RANI) participating in the 2024 Maxim Healthcare Virtual Summit?
Who will represent Rani Therapeutics (RANI) at the 2024 Maxim Healthcare Virtual Summit?
What is the focus of Rani Therapeutics (RANI) as a biotherapeutics company?
How can interested parties access the Rani Therapeutics (RANI) fireside chat at the 2024 Maxim Healthcare Virtual Summit?
